Adjuvant chemotherapy after radical resection of squamous cell carcinoma in the thoracic esophagus: Who benefits? A retrospective study

Digestive Surgery

Volumn 20, Issue 3, 2003, Pages 229-235

  Heroor, Anil ^a   Fujita, Hiromasa ^a   Sueyoshi, Susumu ^a   Tanaka, Toshiaki ^a   Toh, Uhi ^a   Mine, Takashi ^a   Sasahara, Hiroko ^a   Sudo, Tomoya ^a   Matono, Satoru ^a   Yamana, Hideaki ^a   Shirouzu, Kazuo ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cisplatin and fluorouracil; Esophageal cancer; Metastasis positive lymph nodes; Postoperative adjuvant chemotherapy; Radical esophagectomy

Indexed keywords

CISPLATIN; FLUOROURACIL; VINDESINE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGUS; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0038526276     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070390     Document Type: Article

References (27)

1. Ruol A, Panel of Experts: Multimodality treatment for non-metastatic cancer of the thoracic esophagus: Results of a Consensus Conference held at the VIth World Congress of the International Society for Diseases of the Esophagus. Dis Esoph 1996;9(suppl 1):39-55.
2. Orringer MB: Transthoracic versus transhiatal esophagectomy: What difference does it make? Ann Thorac Surg 1987;44:116-118.
3. Medical Research Council Oesophageal Cancer Working Party. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: A randomized controlled trial. Lancet 2001;359:1727-1733.
4. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TPJ: A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462-467.
5. Bosset JF, Gignoux M, Triboulet JP, Tiret E, Mantion G, Elias D, Lozach P, Ollier JC, Pavy JJ, Mercier M, Sahmoud T: Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997;337:161-167.
6. Geh JI, Crellin AM, Glynne-Jones R: Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer. Br J Surg 2001;88:338-356.
7. Kelsen DP, Ginsberg R, Pajak TF, Sheahan DG, Gunderson L, Mortimer J, Estes N, Haller DG, Ajani J, Kocha W, Minsky BD, Roth JA: Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998;339:1979-1984.
8. Bhansali MS, Vaidya JS, Bhatt RG, Patil PK, Badwe RA, Desai PB: Chemotherapy for carcinoma of the esophagus: A comparison of evidence from meta-analysis of randomized trials and of historical control studies. Ann Oncol 1996;7:355-359.
9. Urschel JD, Vasan H, Blewett CJ: A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for respectable esophageal cancer. Am J Surg 2002;183:274-279.
10. Malthaner R, Fenlon D: Preoperative chemotherapy for respectable thoracic esophageal cancer (Cochrane review). Cochrane Lib 2002;3:AB001556.
11. Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M: Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001;19:305-313.
12. Ando N, Iizuka T, Kakegawa T, Isono K, Watanabe H, Ide H, Tanaka O, Shinoda M, Takiyama W, Arimori A, Ishida K, Tsugane S: A randomised trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: The Japan Clinical Oncology Group study. J Thorac Cardiovasc Surg 1997;114:205-209.
13. Lehnert T: Multimodal therapy for squamous carcinoma of the oesophagus. Br J Surg 1999;86:727-739.
14. Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y: Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 1994;220:364-373.
15. Nishimaki T, Suzuki T, Suzuki S, Kuwabara S, Hatakeyama K: Outcomes of extended radical esophagectomy for thoracic esophageal cancer. J Am Coll Surg 1998;186:306-312.
16. Korst RJ, Rusch VW, Venkatraman E, Bains MS, Burt ME, Downey RJ, Ginsberg RJ: Proposed revision of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg 1998;115:660-670.
17. Nigro JJ, DeMeester SR, Hagen JA, Demeester TR, Peters JH, Kiyabu M, Campos GM, Oberg S, Gastal O, Crookes PF, Bremner CG: Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy. J Thorac Cardiovasc Surg 1999;117:960-968.
18. Tachibana M, Yoshimura H, Kinugasa S, Dhar DK, Shibakita M, Ohno S, Ueda S, Fujii T, Nagasue N: Clinicopathologic factors correlated with number of metastatic lymph nodes in oesophageal cancer. Digest Liver Dis 2001;33:534-538.
19. International Union Against Cancer (UICC): TNM Classification of Malignant Tumours, ed 5. New York, Wiley-Liss, 1997.
20. Bumm R, Wong J: More or less surgery for esophageal cancer: Extent of lymphadenectomy in esophagectomy for squamous cell esophageal carcinoma: How much is necessary? Dis Esoph 1994;7:151-155.
21. Kakegawa T, Fujita H, Yamana H: Illustration of surgery for carcinoma in the thoracic esophagus; in Sato T, Iizuka T (eds): Color Atlas of Surgical Anatomy for Esophageal Cancer. Tokyo, Springer, 1992, pp 91-116.
22. Fujita H, Kakegawa T, Yamana H, Shima I, Toh Y, Tomita Y, Fujii T, Yamasaki K, Higaki K, Noake T, Ishibashi N, Mizutani K: Mortality and morbidity rates, postoperative course, quality of life and prognosis after extended radical lymphadenectomy for esophageal cancer: Comparision of three-field lymphadenectomy with two-field lymphadenectomy. Ann Surg 1995;222:654-662.
23. National Cancer Institute: Common toxicity criteria. NCI-CTC Version 2.0, Jan. 30, 1998.
24. Japanese Society for Esophageal Diseases: Guidelines for Clinical and Pathologic Studies on Carcinoma of the Esophagus, ed 9. Tokyo, Kanehara 2001, p 23.
25. Ando N, Iizuka T, Ide H, Ishida K, Shinoda M, Nishimaki T, Takiyama W, Watanabe H, Koide Y, Kinjo Y, Fukuda H: A randomized trial of surgery alone vs surgery plus postoperative chemotherapy with cisplatin and 5-fluorouracil for localized squamous carcinoma of the thoracic esophagus: The Japan Clinical Oncology Group Study (JCOG 9204). Proc Am Soc Clin Oncol 1999;18:269a(1034).
26. Bedard ELR, Inculet RI, Malthaner RA, Brecevic E, Vincent M, Dar R: The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma. Cancer 2001;91:2423-2430.
27. Siewert JR, Stein HJ: Lymph-node dissection in squamous cell esophageal cancer - Who benefits? Langenbecks Arch Surg 1999;384:141-148.